Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Magnus Ingelman-Sundberg

Showing results (1-10 of 284) with videos related to

Pageof 29
Sort By:
Trends in Pharmacological Sciences|April 6, 2004
Pharmacogenetics of cytochrome P450 and its applications in drug therapy: the past, present and futureMagnus Ingelman-Sundberg
Clinical Pharmacology and Therapeutics|August 5, 2024
Pharmacogenomic Prescribing Guidelines: Are They Always Useful?Magnus Ingelman-Sundberg
Toxicology|December 31, 2002
Polymorphism of cytochrome P450 and xenobiotic toxicityMagnus Ingelman-Sundberg
Advances in Pharmacology (San Diego, Calif.)|August 11, 2022
Cytochrome P450 polymorphism: From evolution to clinical useMagnus Ingelman-Sundberg
Naunyn-Schmiedeberg'S Archives of Pharmacology|October 24, 2003
Human drug metabolising cytochrome P450 enzymes: properties and polymorphismsMagnus Ingelman-Sundberg
Pharmacological Research|January 4, 2020
Translation of pharmacogenomic drug labels into the clinic. Current problemsMagnus Ingelman-Sundberg
Clinical Pharmacology and Therapeutics|October 11, 2025
Dietary-Driven Gene ExpansionMagnus Ingelman-Sundberg
Trends in Pharmacological Sciences|December 28, 2014
Interview with Magnus Ingelman-SundbergMagnus Ingelman-Sundberg
Pharmacogenomics|May 13, 2022
The missing heritability in pharmacogenomics: role of NFIB and other factorsMagnus Ingelman-Sundberg
The New England Journal of Medicine|February 8, 2008
Pharmacogenomic biomarkers for prediction of severe adverse drug reactionsMagnus Ingelman-Sundberg
Pageof 29

Showing results (1-10 of 284) with videos related to

Sort By:
Pageof 29
Trends in Pharmacological Sciences|April 6, 2004
Pharmacogenetics of cytochrome P450 and its applications in drug therapy: the past, present and futureMagnus Ingelman-Sundberg
Clinical Pharmacology and Therapeutics|August 5, 2024
Pharmacogenomic Prescribing Guidelines: Are They Always Useful?Magnus Ingelman-Sundberg
Toxicology|December 31, 2002
Polymorphism of cytochrome P450 and xenobiotic toxicityMagnus Ingelman-Sundberg
Advances in Pharmacology (San Diego, Calif.)|August 11, 2022
Cytochrome P450 polymorphism: From evolution to clinical useMagnus Ingelman-Sundberg
Naunyn-Schmiedeberg'S Archives of Pharmacology|October 24, 2003
Human drug metabolising cytochrome P450 enzymes: properties and polymorphismsMagnus Ingelman-Sundberg
Pharmacological Research|January 4, 2020
Translation of pharmacogenomic drug labels into the clinic. Current problemsMagnus Ingelman-Sundberg
Clinical Pharmacology and Therapeutics|October 11, 2025
Dietary-Driven Gene ExpansionMagnus Ingelman-Sundberg
Trends in Pharmacological Sciences|December 28, 2014
Interview with Magnus Ingelman-SundbergMagnus Ingelman-Sundberg
Pharmacogenomics|May 13, 2022
The missing heritability in pharmacogenomics: role of NFIB and other factorsMagnus Ingelman-Sundberg
The New England Journal of Medicine|February 8, 2008
Pharmacogenomic biomarkers for prediction of severe adverse drug reactionsMagnus Ingelman-Sundberg
Pageof 29